Form 20-F Achilles Therapeutics For: Dec 31

Related Keywords

Israel ,Russia ,Chiron ,Zabaykal Skiy Kray ,Odense ,Syddanmark ,Denmark ,Liechtenstein ,Canada ,Norway ,Delaware ,United States ,City Of New York ,New York ,Luxembourg ,Germany ,Geneva ,Genè ,Switzerland ,Japan ,Connecticut ,Helsinki ,Eteläuomen Läi ,Finland ,Washington ,New Zealand ,South Korea ,Northern Ireland ,Craigavon ,United Kingdom ,Deventer ,Overijssel ,Netherlands ,Hong Kong ,Guernsey ,Ukraine ,Singapore ,Dover ,State Of New York ,Channel Islands ,Guernsey General ,Stevenage ,Hertfordshire ,London ,City Of ,Nevada ,Naarden ,Noord Holland ,Pennsylvania ,China ,Cambridge ,Cambridgeshire ,Houten ,Utrecht ,Gooimeer ,Netherlands General ,Chile ,Philadelphia ,Malaysia ,Australia ,California ,Ireland ,South Africa ,District Of Columbia ,Iceland ,America ,British ,Japanese ,American ,Great Britain ,Sergio Quezada ,Edwin Moses ,Michael Giordano ,Christopher Klebanoff ,Danielcc Hood ,Michaelf Giordano ,Felixj Baker ,Scott Antonia ,Westend Sa ,Julie Oneill ,Rogier Rooswinkel ,Amaury Wittouck ,Ben Creelan ,Cassian Yee ,Robert Coutts ,Julianc Baker ,Elizabeth Jaffee ,Claude Debussylaan ,Alena Gros ,Eli Lilly ,Markwin Velders ,Carsten Boess ,Karl Peggs ,Bernhard Ehmer ,Roel Bulthuis ,Miraj Ali ,Stichting Administratiekantoor Westend ,Chris Hollowood ,Christopher Hollowood ,Forbion Capital Fund Iv Co ,Member Of Remuneration Committee ,Safety Monitoring Committee ,Regulatory Agency ,Public Company Accounting Oversight Board ,Cambridge University ,Gene Therapy Catapult Manufacturing Centre In Stevenage ,Delaware Supreme Court ,Company United Kingdom ,Kingdom Joint Committee On ,International Operations ,European Commission ,Foreign Corporation ,Super Office ,Syncona Portfolio ,Research Activities ,Organization Controls ,Smaller Reporting Company Status ,Party Transactions ,Therapeutics Ltd ,Head Of Development ,Member Of The Royal College Medicine ,United States District Court ,Nasdaq Stock Market ,United Kingdom Government Financial Services Compensation Scheme ,Nasdaq ,Corporate Affairs At Kiniksa Pharmaceuticals Ltd ,Clinical Development ,Iovance Biotherapeutics Inc ,Centers For Medicare Medicaid Services ,York Mellon Corporation ,Wales Forum Provision ,Payments Program ,Medicaid Drug Rebate Program ,Company Registration Statement On Form ,University Of Odense ,Bank Secrecy ,Invus Public Equities Advisors ,Artal Group Sa ,Us Supreme Court ,United States Is Cogency Global Inc ,Partnership Share ,Adaptimmune Therapeutics ,European Union Do ,Adss For Syncona Portfolio ,Articles Of Association ,Translational Science Program ,Royal College Of Pathologists ,Gene Therapies Advisory Committee ,Member Of Audit Committee ,Dartmouth Medical School ,Master Service Agreement ,Party Transaction ,Development Expenses ,Epizyme Inc ,Ireland At Gilead Sciences Inc ,Cancer Research United Kingdom ,European Union ,Cancer Research Technology ,Tribunal Tax Chamber ,Incentive Compensation Program ,Avidity Biosciences Inc ,Agreement The Company ,Cell Therapy Catapult ,Office Of Therapeutic Products ,Artal Internationals Ca International ,Takeover Panel ,Pediatric Development ,Exchange Commission ,Fund Election ,Member Of Research Development Committee ,Member Of Nominating Committee ,Achilles Therapeutics United Kingdom ,Pediatric Committee ,Johns Hopkins University ,Public Accounting Firm ,Clearance Services ,Forbion Capital Fund Iv Cooperatief ,Department Of Health ,Kite Pharma Inc ,Turnstone Biologics Corp ,American Institute Of Certified Public Accountant Accounting ,Autolus Therapeutics ,Money Laundering Program ,International Data Transfer Agreement Or Addendum ,Product Development ,Partner Of Syncona Ltd ,Committee For Advanced Therapies ,Angus Chemical Company ,Office Of Foreign Assets Control Anti ,Royal Free Hospital Centre For Cell ,International Financial Reporting Standards ,Id Exchange ,Office Actions ,Monitoring Committee ,Office Of Tissues ,University Of Sheffield ,University Of Reading ,Principal At Mckinsey Co ,Auditor Firm ,Weill Cornell Medical Center ,Corporation Tax ,Achilles Therapeutics Us Inc ,Remuneration Committee ,Oxford University ,National Insurance ,Public Company Accounting Oversight Board United States ,Foreign Investment Company ,Syncona Holdings ,Audit Committee Financial Expert ,Human Tissue Authority ,Development Of The Company ,United States Supreme Court ,Contract Manufacturing Organization ,Astrazeneca ,Us Biological Products Development ,European Patent Office ,Audit Committee ,Company Consolidated Statements Of Operations ,Health Care ,European Council ,Obsidian Therapeutics Inc ,United Kingdom Companies ,Nasdaq Listing Qualifications Department ,Pediatric Research Equity ,Syncona Investment Management ,Articles Of The Company ,Instil Bio Inc ,Human Service Office Of Inspector ,Bristol Myers Squibb Company ,Syncona Portfolio Limited Is Frances House ,Rocket Pharmaceuticals Inc ,Organization For Economic ,European Commission Standard Contractual Clauses ,Committee For Medicinal Products Human ,Baker Brothers Life Sciences ,Cass Business School ,Children Health Insurance Program ,Us Federal Forum Provision ,Foreign Currency Exchange Risk ,Artal Group ,Imclone Systems ,Oncology Center ,Us Congress ,Securities Exchange ,Artal International Management ,Cancer Immunotherapy At University College London ,Advisory Committee ,Health Insurance Portability ,Exchange Act ,Achilles Therapeutics ,Commission File Number ,Natural Sciences ,Panel On Takeovers ,Hookipa Pharma Inc ,Achilles Therapeutics Plc ,Global Operations At Alexion Pharmaceuticals Inc ,Artal International ,Public Health Service ,Oxford University Medical School ,City University ,Achilles Therapeutics Holdings Limited ,Centers For Medicare ,Memorial Sloan Kettering Cancer Center ,Department Of Justice ,Information Technology ,International Accounting Standards Board ,Revenue Service ,Immunotherapy At University College London Cancer Institute ,Medicaid Services ,Imclone Systems Inc ,Company Articles Of Association ,Genetics Inc ,Drug Administration ,Therapeutics Inc ,Growth Company ,European Parliament ,European Medicines Agency ,File Number ,Primary Standard ,Code Number ,General Counsel ,Depositary Shares ,Global Select Market ,American Depositary ,Annual Report ,Securities Exchange Act ,Interactive Data File ,Regulations T ,Financial Accounting Standards Board ,Accounting Standards Codification ,Sarbanes Oxley Act ,Financial Reporting Standards ,American Depositary Shares ,Securities Act ,Financial Review ,Investigational New Drug Application ,Biologics License Application ,United Kingdom Medicines ,Material Acquisition Platform ,Middle East ,Financial Position ,Business Operations ,Senior Management ,Statement Regarding Forward Looking ,Future Cash ,Independent Data ,Cancer Evolution ,West London ,Clinigen Limited ,Royal Free Hospital ,Gene Therapy Catapult ,Kite Pharma ,Instil Bio ,Neogene Therapeutics ,Obsidian Therapeutics ,Foreign Corrupt Practices Act ,Regulatory Review ,Advanced Therapies ,Biologics Evaluation ,Therapeutic Products ,Orphan Drug Act ,Consolidated Appropriations Act ,Orphan Drug ,Priority Review ,Drug Omnibus Reform Act ,Breakthrough Therapy Designation ,Breakthrough Therapy ,Fast Track ,Time Oncology Review ,Human Service Office ,Inspector General ,Claims Act ,False Claims Act ,Affordable Care Act ,Biologics Price Competition ,Innovation Act ,Government Regulation ,Member States ,Member State ,Data Protection Regulation ,United Kingdom Data Protection Act ,Standard Contractual Clauses ,International Data Transfer Agreement ,United Kingdom Government ,Data Protection ,Digital Information Bill ,Data Reform Bill ,United Kingdom Adequacy Decision ,Federal Trade Commission Act ,California Consumer Privacy Act ,California Privacy Rights Act ,Intelligence Act ,Cancer Research Technology Limited ,Drug Price Competition ,Patent Term Restoration Act ,Hatch Waxman Amendments ,Molecular Pathology ,Leahy Smith America Invents Act ,America Invents Act ,Intellectual Property ,Bank Secrecy Act ,General Meeting ,Jumpstart Our Business Startups Act ,Regulation Fair Disclosure ,United Kingdom Companies Act ,Companies Act ,Nasdaq Global Select Market ,Nasdaq Global Select ,Nasdaq Listing Rule ,Dodd Frank Wall Street Reform ,Consumer Protection Act ,United States Supreme ,United Kingdom City Code ,Takeover Code ,Southern District ,Wales Forum ,Forum Provision ,Internal Revenue Code ,Ten Percent Shareholder ,Ten Percent Shareholders ,His Majesty ,Economic Co Operation ,Base Erosion ,Profit Shifting ,Internal Revenue Service ,Good Manufacturing Practice ,Human Medicines Regulations ,Northern Ireland Protocol ,Trials Regulation ,United Kingdom Wide ,Windsor Framework ,Regulatory Framework ,Gene Therapy ,Achilles Therapeutics United Kingdom Limited ,Achilles Therapeutics Limited ,Cogency Global ,Chief Executive ,Managing Partner ,Investment Director ,Nightstar Therapeutics ,Blue Earth Diagnostics ,Bracco Imaging ,Chief Scientific Officer ,Professor Sergio Quezada ,Chief Medical Officer ,Professor Karl Peggs ,Transplant Science ,University College ,Professor Peggs ,University College London Hospitals ,Scientific Advisory Board ,Genetic Basis ,Current Therapies ,Cell October ,Cell Therapy ,Non Small Cell Lung Cancer ,Trial Designs ,Neoantigen Targetingt Cell Therapies Led ,Durable Complete Responses ,Mouse Models ,Net Process Delivered Higher Clonal Reactivity ,Net Produced Higher Amounts ,Effector Cytokines ,Tissue Therapeutics ,Royal Free Campus ,Cell Therapy Catapult Limited ,Gene Therapy Catapult Manufacturing Centre ,Sycamore House ,Federal Food ,Cosmetic Act ,Public Health Service Act ,Institutional Review Board ,Independent Data Safety ,Prescription Drug User Fee Act ,Pediatric Research Equity Act ,Complete Response Letter ,Century Cures ,Century Cures Act ,Real Time Oncology Review ,Term Restoration ,Occupational Safety ,Health Act ,Resource Conservancy ,Recovery Act ,Control Act ,Regulation Outside ,Clinical Trials Regulation ,Clinical Trials Directive ,Clinical Trials Information System ,Concerned Member States ,Reference Member ,Concerned Member ,Medicinal Products ,Human Use ,Cells Directive ,Human Tissue ,Human Tissue Act ,Human Application ,Marketing Exclusivity ,Pediatric Investigation Plan ,Under Article ,Devices Regulations ,Devices Directive ,In Vitro Diagnostic Devices Regulation ,Vitro Diagnostics Directive ,United Kingdom Joint Committee ,Medical Devices Regulations ,Kingdom Responsible ,Healthcare Laws ,Anti Kickback Statute ,Accountability Act ,Physician Payments Sunshine Act ,Patient Protection ,Education Reconciliation Act ,Health Insurance Program ,Open Payments Program ,Drug Rebate Program ,President Biden ,American Rescue Plan Act ,Statutory Pay As You Go Act ,American Taxpayer Relief Act ,Inflation Reduction Act ,Try Act ,Hammersmith Road ,Capital Resources ,Global Political ,Economic Events ,Founding Institutions ,Vaccine Option ,Assignment Agreement ,Tax Expenses ,Qualitative Disclosures About Market Risks ,Kingdom Value Added Tax ,Years Ended December ,Ended December ,Cash Used ,Cash Provided ,Smaller Reporting Company ,Financial Condition ,Business Overview ,Accounting Policies ,Significant Judgments ,Fair Value ,Free Interest ,Executive Officer ,Executive Directors ,Chief Executive Officer ,Syncona Ltd ,Investment Partner ,Chief Financial Officer ,Finance Director ,Subsidiary Financial Controller ,New College ,Royal College ,Cancer Immunology ,University College London Cancer Institute ,Molecular Biology ,Pontificia Universidad Cat ,Memorial Sloan Kettering Cancer ,Clinical Advisor ,Interim Chief Medical Officer ,Senior Vice President ,Johns Hopkins ,Executive Vice President ,Corporate Affairs ,Kiniksa Pharmaceuticals ,Rocket Pharmaceuticals ,Avidity Biosciences ,Fresenius Biotech ,Supervisory Board ,Global Operations ,Alexion Pharmaceuticals ,Vice President ,Gilead Sciences ,Hookipa Pharma ,National Institute ,Bioprocessing Research ,Executive Letters ,Annual General ,Employee Shares ,Omnibus Plan ,Vesting Agreements ,Registration Statement ,Share Purchase ,Share Purchase Plan ,United Kingdom Based ,Share Incentive Plan ,Partnership Shares ,Matching Shares ,Related Party Transactions ,New York Mellon ,Greater Shareholders ,Portfolio Limited ,Invus Public Equities ,Syncona Portfolio Limited ,Syncona Holdings Limited ,Syncona Investment Management Limited ,Syncona Limited ,Frances House ,Sir William Place ,Peter Port ,Forbion Capital Fund ,Forbion Management ,Ordinary Shares ,Beneficial Ownership ,Beneficial Ownership Limitation ,Baker Entities ,Public Equities ,Administratiekantoor Westend ,Valley Park ,Rue De La Vall ,Major Shareholders ,Income Tax Considerations ,United Kingdom Holders ,Individual Savings Account ,Self Invested Personal Pension ,First Tier Tribunal ,Tax Chamber ,New York Mellon Corporation ,United Kingdom Holder ,Stamp Duty Reserve ,Finance Bill ,United Kingdom Finance Act ,Treasury Regulations ,Qualified Electing Fund Election ,Information Statement ,Foreign Investment Company Rules ,Foreign Financial ,Specified Foreign Financial Assets ,Financial Statements ,Qualitative Disclosures ,British Pounds Sterling ,Dividend Arrearages ,Security Holders ,Disclosure Controls ,Exchange Act Rules ,Internal Control ,Integrated Framework ,Sponsoring Organizations ,Treadway Commission ,Attestation Report ,Registered Public Accounting ,Committee Financial ,Nasdaq Stock ,Accountant Fees ,Listing Standards ,Equity Securities ,Business Conduct ,Nasdaq Rule ,Voting Rights ,Regarding Foreign Jurisdictions ,Chief Financial ,Computer Science ,Chief Legal ,Independent Registered Public Accounting ,Consolidated Financial ,Accounting Standards Update ,Going Concern ,Balance Sheet ,Restricted Cash ,Consolidated Balance ,Consolidated Statements ,Asset Retirement ,Environmental Obligations ,American Institute ,Certified Public Accountant Accounting ,Evaluation Guide ,Privately Held Company Equity Securities Issued ,Reportable Segment Disclosures ,Income Tax Disclosures ,Business Entities ,Government Assistance ,Convertible Preferred Shares ,Royal Free London ,Pond Street ,Stevenage Bioscience Catalyst ,Gunnels Wood Road ,Good Manufacturing Practices ,License Agreement ,United Kingdom Generally ,Finance Act ,Internal Revenue ,